1989
New Epidemiologic Evidence Confirming That Bias Does Not Explain the Aspirin/Reye's Syndrome Association
Forsyth B, Horwitz R, Acampora D, Shapiro E, Viscoli C, Feinstein A, Henner R, Holabird N, Jones B, Karabelas A, Kramer M, Miclette M, Wells J. New Epidemiologic Evidence Confirming That Bias Does Not Explain the Aspirin/Reye's Syndrome Association. JAMA 1989, 261: 2517-2524. PMID: 2704111, DOI: 10.1001/jama.1989.03420170061031.Peer-Reviewed Original ResearchConceptsSyndrome AssociationCase subjectsMedical record review studyRecord review studyCase-control studyNew epidemiologic evidencePotential recall biasSeverity of symptomsEpidemiologic evidenceReye's syndromeEpidemiologic investigationsControl groupDiagnostic biasSusceptibility biasRecall biasBiphasic patternSyndromeAssociationReview studyPotential sourceSubjectsAspirinHospitalIllnessSymptoms
1984
Resolving the Pneumococcal Vaccine Controversy: Are There Alternatives to Randomized Clinical Trials?
Clemens J, Shapiro E. Resolving the Pneumococcal Vaccine Controversy: Are There Alternatives to Randomized Clinical Trials? Clinical Infectious Diseases 1984, 6: 589-600. PMID: 6390636, DOI: 10.1093/clinids/6.5.589.Peer-Reviewed Original ResearchA controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.
Shapiro E, Clemens J. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Annals Of Internal Medicine 1984, 101: 325-30. PMID: 6380367, DOI: 10.7326/0003-4819-101-3-325.Peer-Reviewed Original ResearchConceptsIncreased risk of pneumococcal infectionRisk of pneumococcal infectionEfficacy of pneumococcal vaccineSystemic pneumococcal infectionPneumococcal infectionPneumococcal vaccineVaccine protective efficacyIncreased riskProtective efficacyCase-control studyOdds ratioVaccine efficacyHigh riskMatched controlsPatientsInfectionConfounding variablesEfficacyVaccine